 |
 |

Management of Occult Medullary Thyroid CarcinomaEvidenced Only by Serum Calcitonin Level Elevations After Apparently Adequate Neck Operations
Melvin A. Block, MD;
Charles E. Jackson, MD;
Armen H. Tashjian, Jr, MD
Arch Surg. 1978;113(4):368-372.
Abstract
 |  |
Following operation for medullary thyroid carcinoma, elevated serum calcitonin levels were present in 18 patients who had no clinically evident residual tumor. In eight of these patients, additional operations have been performed to achieve an appropriate thyroidectomy and cervical lymph node dissection. In six of these eight, elevated serum calcitonin concentrations persist. Extensive clinical examinations failed to identify a metastatic focus of carcinoma. Serum calcitonin concentrations have remained relatively stable for up to six years (average, 3.9 years) of observations in 12 patients after initial or only operations performed from one to 13 years (average 7.3 years) previously. This suggests that microscopic metastases of this carcinoma can remain relatively dormant for years. The management of medullary thyroid carcinoma requires initially adequate cervical operations, periodic serum calcitonin measurements postoperatively, reoperation if adequate neck surgery has not been performed and if serum calcitonin levels remain elevated and only periodic reevaluation for other asymptomatic patients with persistently elevated concentrations of serum calcitonin.
(Arch Surg 113:368-372, 1978)
Author Affiliations
From the Departments of Surgery (Dr Block) and Medicine (Dr Jackson), Henry Ford Hospital, Detroit; and the Laboratory of Pharmacology, Harvard School of Dental Medicine (Dr Tashjian), and the Department of Pharmacology (Dr Tashjian), Harvard Medical School, Boston.
Footnotes
Read before the 85th annual meeting of the Western Surgical Association, Las Vegas, Nov 14, 1977.
Reprint requests to Department of Surgery, Henry Ford Hospital, 2799 W Grand Blvd, Detroit, MI 48202 (Dr Block).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Successful Surgical Removal of Occult Metastases of Medullary Thyroid Carcinoma Recurrences with the Help of Immunoscintigraphy and Radioimmunoguided Surgery
de Labriolle-Vaylet et al.
Clin. Cancer Res. 2000;6:363-371.
ABSTRACT
| FULL TEXT
Detection of Medullary Thyroid Carcinoma and Regional Lymph Node Metastases by Magnetic Resonance Imaging
Wang et al.
Arch Otolaryngol Head Neck Surg 1999;125:842-848.
ABSTRACT
| FULL TEXT
They Call It Competition: Presidential Address
Block
Arch Surg 1989;124:771-777.
ABSTRACT
Lymph Node Metastases: Indicators, but Not Governors of Survival
Cady
Arch Surg 1984;119:1067-1072.
ABSTRACT
Clinical Characteristics Distinguishing Hereditary From Sporadic Medullary Thyroid Carcinoma: Treatment Implications
Block et al.
Arch Surg 1980;115:142-148.
ABSTRACT
|